A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma

Clinical trial NCT00359294 · TERMINATED

Trial details

NCT number: NCT00359294
Sponsor: PharmaMar
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Lymphoma

Start date: 2006-05-01
Primary completion: 2008-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.